Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: A Trauma-Informed Approach for Positive Youth Development for Montana Students [NA]
Clinical trial examining a trauma-informed approach to positive youth development for Montana students has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder [Phase 3]
Phase 3 trial update for brexpiprazole as adjunctive therapy in major depressive disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) [Phase 3]
Phase 3 trial update on efficacy, safety and tolerability of agomelatine sublingual tablets for major depressive disorder (MDD) completed.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) [Phase 3]
Open-label long-term safety and tolerability study (52 weeks) of agomelatine sublingual tablets in major depressive disorder has terminated …
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder [Phase 3]
Phase 3 trial update on agomelatine for major depressive disorder focusing on efficacy, safety, and tolerability.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder [Phase 3]
Phase 3 trial assessing efficacy, safety, and tolerability of agomelatine in preventing relapse of major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD) [Phase 3]
Phase 3 clinical trial evaluating agomelatine 25 or 50 mg versus placebo and paroxetine for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Brainsway DTMS for Treatment of MDD Using iTBS [Phase 4]
Phase 4 clinical trial update for Brainsway DTMS using iTBS in major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder [Phase 3]
Phase 3 trial update on efficacy, safety, and tolerability of agomelatine in treating Major Depressive Disorder.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder [Phase 3]
Phase 3 trial assessing efficacy, safety, and tolerability of agomelatine sublingual tablets for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder [Phase 2]
Phase 2 trial evaluating MIN-117 for major depressive disorder has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy [Phase 4]
Phase 4 clinical trial update examining hippocampal volume in young patients with major depressive disorder before and after combined antide…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine Levels [Phase 4]
A Phase 4 clinical trial assessing how electroconvulsive therapy (ECT) affects homocysteine levels in patients with depressive disorders; co…
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: Dexmedetomidine Adjuvant Treatment for Depressed Patients Undergoing ECT [Phase 4]
Phase 4 clinical trial investigating dexmedetomidine as an adjuvant treatment for patients with depressive disorders undergoing electroconvu…
-
CLINICAL_TRIALS trial_result · 2020-12-07Clinical Trial Update: Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function [NA]
A completed clinical trial on internet-based cognitive behavioral therapy for major depressive disorder, reporting results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder [Phase 2]
A Phase 2 trial evaluating SAGE-217 for moderate to severe major depressive disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: NMDA Modulation in Major Depressive Disorder in Late- Life [Phase 2]
Phase 2 trial update on NMDA modulation for major depressive disorder in late life has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Efficacy of Resveratrol in Depression [Phase 4]
Phase 4 clinical trial update on resveratrol for depression; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Intervening Early With Neglected Children [Phase 1, Phase 2]
A mixed Phase 1/Phase 2 clinical trial update titled Intervening Early With Neglected Children investigating Conduct Disorder and ADHD (with…
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Cognitive Behavioral Therapy for Adherence in Patients With Type 2 Diabetes [NA]
A completed clinical trial evaluating cognitive behavioral therapy to improve adherence in patients with type 2 diabetes and depression.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: The UTHealth Ketamine Project [Phase 2]
Phase 2 trial update for the UTHealth Ketamine Project in treatment-resistant depression and major depressive disorder (terminated with resu…
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness [NA]
Clinical trial update on a mobile texting intervention for people with serious mental illness has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: PEER Interactive to Inform the Prescription of Medications [Phase 4]
Phase 4 clinical trial update involving PEER Interactive to inform prescription of medications for depression.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: The ISLAND Study: InSuLa Assessed Needs for Depression [Phase 4]
Phase 4 clinical trial assessing depression treatment in the ISLAND study; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine Treatment [Phase 4]
Phase 4 trial evaluating reward processing in major depressive disorder before and after desvenlafaxine treatment.